medicationControlled

Lisdexamfetamine

Also known as: Vyvanse

Chemical structure of Lisdexamfetamine (PubChem CID 11597698)
Structure via PubChem
Half-life
11 h
Typical timing
morning
Food rule
either
Default unit
mg

Studied for

Overview

Lisdexamfetamine, commonly known by its brand name Vyvanse, is a central nervous system (CNS) stimulant medication. It is a prodrug of dextroamphetamine, meaning it is inactive until it is metabolized in the body into its active form. Lisdexamfetamine is primarily prescribed for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children aged 6 and older, and for moderate to severe Binge Eating Disorder (BED) in adults. As a controlled substance, its use is regulated due to its potential for abuse and dependence. The medication is taken orally and is available in capsule and chewable tablet forms. Its unique prodrug nature contributes to a smoother and longer-lasting effect compared to immediate-release stimulants, as the conversion to dextroamphetamine occurs gradually in the gastrointestinal tract and blood. (FDA label, DrugBank)

Deep dive

Tap a section to expand.

Known interactions

  • Category rule: supplement × medication
    Note

    Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).

    Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.

  • Category rule: vitamin × medication
    Note

    Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).

    Specific pairs are checked against a licensed source; confirm with your provider.

  • Compound-pair rule
    Avoid

    MAOI blocks catecholamine breakdown; combining with sympathomimetics can trigger hypertensive crisis.

    Do not combine.

  • Compound-pair rule
    Avoid

    MAOI blocks catecholamine breakdown; combining with sympathomimetics can trigger hypertensive crisis.

    Do not combine.

  • Compound-pair rule
    Avoid

    MAOI blocks catecholamine breakdown; combining with sympathomimetics can trigger hypertensive crisis.

    Do not combine.

  • Compound-pair rule
    Caution

    Additive cardiovascular stimulation (heart rate, blood pressure).

    Limit caffeine when using prescription stimulants; monitor blood pressure.

  • Compound-pair rule
    Avoid

    Yohimbine + stimulants sharply increases sympathetic tone and can trigger arrhythmia.

    Do not combine.

Frequently asked

Sources referenced

* FDA (U.S. Food and Drug Administration) * DrugBank * PubChem * NIH ODS (National Institutes of Health Office of Dietary Supplements) * Mayo Clinic * MedlinePlus * Cochrane Library

Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.

Related compounds

Others in the medication category or studied for the same goals.

Related benefits

Other compounds studied for the same benefits as Lisdexamfetamine.

Continue exploring

See every compound Stackwise catalogues for these goals.

Track Lisdexamfetamine in Stackwise

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →